BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34204447)

  • 21. Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.
    Stegeman H; Kaanders JH; Verheijen MM; Peeters WJ; Wheeler DL; Iida M; Grénman R; van der Kogel AJ; Span PN; Bussink J
    Mol Cancer; 2013 Nov; 12(1):133. PubMed ID: 24192080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATR inhibition sensitizes HPV
    Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE
    Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis.
    Šalovská B; Fabrik I; Ďurišová K; Link M; Vávrová J; Řezáčová M; Tichý A
    Int J Mol Sci; 2014 Jul; 15(7):12007-26. PubMed ID: 25003641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
    Teng PN; Bateman NW; Darcy KM; Hamilton CA; Maxwell GL; Bakkenist CJ; Conrads TP
    Gynecol Oncol; 2015 Mar; 136(3):554-61. PubMed ID: 25560806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor.
    Knegtel R; Charrier JD; Durrant S; Davis C; O'Donnell M; Storck P; MacCormick S; Kay D; Pinder J; Virani A; Twin H; Griffiths M; Reaper P; Littlewood P; Young S; Golec J; Pollard J
    J Med Chem; 2019 Jun; 62(11):5547-5561. PubMed ID: 31074988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
    Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
    Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
    Sankunny M; Parikh RA; Lewis DW; Gooding WE; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasome regulation of ULBP1 transcription.
    Butler JE; Moore MB; Presnell SR; Chan HW; Chalupny NJ; Lutz CT
    J Immunol; 2009 May; 182(10):6600-9. PubMed ID: 19414815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells.
    Vávrová J; Zárybnická L; Jošt P; Tichý A; Řezáčová M; Šinkorová Z; Pejchal J
    Folia Biol (Praha); 2016; 62(4):167-74. PubMed ID: 27643582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response.
    Heylmann D; Badura J; Becker H; Fahrer J; Kaina B
    Cell Death Dis; 2018 Oct; 9(11):1053. PubMed ID: 30323167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Zhou C; Parsons JL
    Expert Rev Mol Med; 2020 Jul; 22():e3. PubMed ID: 32611474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.
    Leiker AJ; DeGraff W; Choudhuri R; Sowers AL; Thetford A; Cook JA; Van Waes C; Mitchell JB
    Clin Cancer Res; 2015 Jun; 21(12):2792-801. PubMed ID: 25724523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.
    Karukonda P; Odhiambo D; Mowery YM
    Mol Carcinog; 2022 Feb; 61(2):225-238. PubMed ID: 34964992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
    Durant ST; Zheng L; Wang Y; Chen K; Zhang L; Zhang T; Yang Z; Riches L; Trinidad AG; Fok JHL; Hunt T; Pike KG; Wilson J; Smith A; Colclough N; Reddy VP; Sykes A; Janefeldt A; Johnström P; Varnäs K; Takano A; Ling S; Orme J; Stott J; Roberts C; Barrett I; Jones G; Roudier M; Pierce A; Allen J; Kahn J; Sule A; Karlin J; Cronin A; Chapman M; Valerie K; Illingworth R; Pass M
    Sci Adv; 2018 Jun; 4(6):eaat1719. PubMed ID: 29938225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation.
    Fabbrizi MR; Doggett TJ; Hughes JR; Melia E; Dufficy ER; Hill RM; Goula A; Phoenix B; Parsons JL
    Cell Death Discov; 2024 Jun; 10(1):282. PubMed ID: 38866739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting DNA Double-Strand Break Repair Enhances Radiosensitivity of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma to Photons and Protons.
    Vitti ET; Kacperek A; Parsons JL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.
    Nickson CM; Moori P; Carter RJ; Rubbi CP; Parsons JL
    Oncotarget; 2017 May; 8(18):29963-29975. PubMed ID: 28415784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells.
    Köcher S; Zech HB; Krug L; Gatzemeier F; Christiansen S; Meyer F; Rietow R; Struve N; Mansour WY; Kriegs M; Petersen C; Betz C; Rothkamm K; Rieckmann T
    Front Oncol; 2022; 12():765968. PubMed ID: 35719921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.